Evaluation of Salivary RNAs in the Presence of an Adnexal Mass of Ovarian Origin

RecruitingOBSERVATIONAL
Enrollment

250

Participants

Timeline

Start Date

May 4, 2022

Primary Completion Date

April 30, 2026

Study Completion Date

April 30, 2026

Conditions
Ovarian CancerOvarian Cyst BenignBorderline Ovarian Cancer
Interventions
OTHER

Salivary samples

"For patients with a benign ovarian cyst, 1 saliva sample taken at 3 times (concomitant with a visit performed in routine care):~* During the inclusion visit,~* At the postoperative visit,~* At the 6-month follow-up visit~For patients with ovarian cancer, 1 saliva sample taken at different times (concomitant with a visit performed in routine care):~* At the inclusion visit,~* During the postoperative visit,~* At the follow-up visits (6 months post-surgery and then every 6 months until 24 months)~For patients with a borderline ovarian tumor, 1 saliva sample taken at different times (concomitant with a visit performed in routine care):~* At the inclusion visit,~* During the postoperative visit,~* During pre- and post-chemotherapy visits (before and after each cycle)~* During follow-up visits (every 4 months until 24 months)"

Trial Locations (12)

14000

RECRUITING

CHU de Caen, Caen

20600

RECRUITING

CH Bastia, Bastia

35000

RECRUITING

CHU Rennes, Rennes

37044

RECRUITING

CHRU Bretonneau-Tours, Tours

49933

RECRUITING

CHU Angers, Angers

69000

RECRUITING

CHU Lyon Sud / Hospices Civils de Lyon, Lyon

75020

RECRUITING

CHU Tenon, Paris

79021

RECRUITING

CH Niort, Niort

Unknown

RECRUITING

Centre Antoine Lacassagne, Nice

RECRUITING

Clinique La sagesse, Rennes

RECRUITING

CHU Rouen, Hôpital de Bois-Guillaume, Rouen

RECRUITING

Clinique Pasteur, Toulouse

Sponsors

Lead Sponsor

All Listed Sponsors
collaborator

Monitoring Force Group

INDUSTRY

collaborator

iGenSeq

UNKNOWN

lead

ZIWIG

INDUSTRY

NCT05514028 - Evaluation of Salivary RNAs in the Presence of an Adnexal Mass of Ovarian Origin | Biotech Hunter | Biotech Hunter